Closed · CDC-RFA-DP14-1407 · CFDA 93.283 · Discretionary
Enhancing Cancer Genomic Best Practices through Education, Surveillance, and Policy
Federal grant opportunity posted by Centers for Disease Control and Prevention, cataloged on Grants.gov.
- $150K-$350K
- Award range
- Closed
- Status
- June 17, 2014
- Close date
- 5
- Expected awards
The verdict
Enhancing Cancer Genomic Best Practices through Education, Surveillance, and Policy is a closed discretionary listing from Centers for Disease Control and Prevention that offered $150,000 -- $350,000 across 5 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 1,727 other opportunities from Centers for Disease Control and Prevention.
- $150K-$350K
- award range
- Closed
- application status
- 5
- expected awards
- 93.283
- CFDA program
Archived opportunity record
Enhancing Cancer Genomic Best Practices throu… is closed (last close June 17, 2014). The parent program page for CFDA 93.283 is the reliable place to catch re-announcements. Centers for Disease Control and Prevention still indexes 1,727 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed June 17, 2014
Est. Total Funding
$1,500,000
Expected Awards
5
Instrument
Cooperative Agreement
Description
This FOA will allow for the development or expansion of state-based programs to promote applications of evidence-based breast and ovarian cancer genomics best practices through education, surveillance, and policy/systems change. Activities will focus on Hereditary Breast and Ovarian Cancer, but may also include Lynch Syndrome. Several system, policy, provider, and individual level barriers make the appropriate identification and treatment of high risk individuals difficult and this FOA will support state efforts to address these barriers and impact breast and ovarian cancer incidence rates. Funded applicants will develop, enhance, and evaluate education, surveillance, and policy activities related to promotion of breast and ovarian cancer genomics. These activities should take advantage of collaborations between funded applicants and partners, both internal (e.g. cancer registry, comprehensive cancer) and external (e.g., academic medical centers, non-profits, clinical genetics sites). Expected outcomes include the improvement of public and provider knowledge of hereditary cancers, genetic counseling, genetic testing, and associated clinical services, the assessment of the burden of hereditary cancers and use of genetic counseling, genetic testing and associated clinical services, and the improvement in access to and coverage of genetic counseling, genetic testing and associated clinical services for high risk individuals. Women with breast cancer susceptibility 1 and 2 (BRCA1/2) gene mutations have a substantially higher breast and ovarian cancer risk than those without such mutations, with a cumulative risk of developing breast and ovarian cancer up to 57 percent and 40 percent respectively. Women with a personal or family cancer history indicative of a BRCA 1/2 mutation may benefit from genetic counseling and testing. For those who test positive, interventions including chemoprevention, enhanced surveillance or prophylactic mastectomy and oophorectomy can decrease breast cancer incidence and ovarian cancer incidence by up to 95% and 80%, respectively. The United States Preventive Services Task Force (USPSTF) and the National Comprehensive Cancer Network (NCCN), have evidence-based recommendations for genetic counseling and testing for hereditary breast and ovarian cancer. People with Lynch syndrome have a higher likelihood of developing colorectal and other (e.g., gastric, endometrial, and ovarian) cancers. The Evaluation of Genomic Applications in Practice and Prevention (EGAPP™) Working Group found sufficient evidence to recommend offering genetic testing for Lynch syndrome to individuals with newly diagnosed colorectal cancer to reduce morbidity and mortality in relatives.
Catch-all / unrestricted eligibility mark · CDC-RFA-DP14-1407
Grants.gov marks Enhancing Cancer Genomic Best Practices throu… with a catch-all / unrestricted eligibility code (Others (see official listing text)). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Cooperative Agreement. Funding-activity code maps to Health (HL). This eligibility-code string dominates the Centers for Disease Control and Prevention book (1,452 peers, 84% of 1,728).
- Code 25
- Others (see official listing text)
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Parent Grant Program
Centers for Disease Control Investigations and Technical Assistance
Centers for Disease Control and Prevention
Agency Contact
CDC Procurement and Grants Office (PGO) Technical Information Management Section (TIMS) Phone: 770-488-2700 E-mail: pgotim@cdc.gov
More from Centers for Disease Control and Prevention
What to do next
Enhancing Cancer Genomic Best Practices throu… is closed; use the parent program and agency catalog for the next funding cycle.
- Parent CFDA 93.283 may publish future NOFOs under the same assistance listing. Open program
- Centers for Disease Control Investigations an… indexes 3 Grants.gov listings in this extract. Program profile
- Centers for Disease Control and Prevention lists 1,727 other indexed opportunities on PlainGrants. Agency catalog
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |